Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Hyperkalemia

Hyperkalemia from a nephrological and cardiological point of view.

    • Cardiology
    • Congress Reports
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nephrology
    • RX
    • Studies
  • 2 minute read

Patients with cardiac and/or renal insufficiency often experience electrolyte imbalance, which in many cases is life-threatening. Hyperkalemia can be caused by the underlying disease itself, but also by its treatment management. Therefore, in order not to cast out the devil with the Beelzebub, an effective approach specifically tailored to hyperkalemia is needed.

Potassium levels are determined by absorption, distribution, and (predominantly renal) elimination. On average, 1 mmol/kg is absorbed daily through food. The total concentration is then distributed with a ratio of 2% to 98% in the extracellular and intracellular space. The potassium-sodium ATPase is responsible for this. This activity can be modified via different pathways, such as insulin action or β adrenergic receptors, explained Prof. Ralph Kettritz, MD, Berlin (D). These support potassium influx into the intracellular space. Hyperglycemia, α agonists, and inorganic acidosis, on the other hand, cause potassium efflux. Potassium secretion is controlled by the mechanisms of sodium delivery, urine flow, aldosterone, and serum potassium, among others. By shifting potassium into cells and aldosterone-driven renal potassium secretion, the body can basically process high dietary potassium levels. High potassium intake also has beneficial effects on blood pressure and CV events, but also on CKD progression. According to association studies, the optimal potassium level is 4.0-4.6 mmol/l. In addition to CKD, age, diabetes mellitus, and RAAS blockade must also be considered risk factors for hyperkalemia.

The kidney in focus

If too much potassium is supplied to the body, the appropriate countermeasures are already initiated during intestinal absorption. Prof. Dr. med. Mark Dominik Alscher, Stuttgart (D), pointed out that these mechanisms cannot fully take place in the case of impaired kidney function. In this case, acute hyperkalemia can occur very quickly. This is divided into three degrees of severity:

  1. Severity A: 5.0-5.9 mmol/l
  2. Severity B: 6.0-6.9 mmol/l
  3. Severity C: >7.0 mmol/l

Already from severity B the situation can be life-threatening. Accordingly, measures to lower the potassium level should be taken as soon as possible (Fig. 1).

 

 

Effects on the heart

The cardio-renal interaction in systolic heart failure resembles a vicious circle, as Prof. Christiane Angermann, MD, Würzburg (D), explained. If cardiac pump function is reduced, lower renal perfusion and diuresis are the result. This results in congestion, which in turn has an unfavorable effect on the heart. Correspondingly, the rate of hyperkalemia in heart failure increases with decreasing renal function. This leads to a core problem in practice, as this consequence is also evident depending on the therapy and therefore, for example, RAAS inhibitors are discontinued or reduced and potentially life-saving therapies are withheld, the expert said.

In this case, specific therapy of hyperkalemia should rather be considered. Sodium polystyrene sulfonate is available for this purpose, but it is subject to significant limitations, is poorly tolerated and can result in severe gastrointestinal complications. Patiromer offers significantly better tolerability with only mild gastrointestinal side effects such as constipation, as well as good study evidence, Angermann reported. Studies have shown that the potassium blocker allows initiation and up-dosing of treatment with RAAS inhibitors and thus optimized heart failure therapy.

Congress: DGIM

 

CARDIOVASC 2021; 20(2): 31 (published 6/27-21, ahead of print).

Autoren
  • Leoni Burggraf
Publikation
  • CARDIOVASC
Related Topics
  • Heart failure
  • Hyperkalemia
  • Renal failure
Previous Article
  • Rheumatism 2021

News from basic research

  • CME continuing education
  • Education
  • General Internal Medicine
  • Geriatrics
  • Rheumatology
  • RX
  • Studies
View Post
Next Article
  • Alopecia areata

Baricitinib improves hair growth in second Phase III study

  • Dermatology and venereology
  • General Internal Medicine
  • Market & Medicine
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 6 min
  • Treatment of vitiligo

Focus on patient perspective and disease activity

    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 5 min
  • Vaccine-preventable respiratory diseases

RSV and pneumococci: recommendations for risk groups

    • Congress Reports
    • General Internal Medicine
    • Infectiology
    • Pediatrics
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 5 min
  • Circadian rhythm in asthma

Chronotherapy can improve control

    • Allergology and clinical immunology
    • General Internal Medicine
    • Pneumology
    • RX
    • Studies
View Post
  • 6 min
  • Update on diagnostics, risk stratification and therapy

Acute myeloid leukemia 2025

    • Education
    • Hematology
    • Oncology
    • RX
    • Studies
View Post
  • 4 min
  • New practice guideline for fibromyalgia syndrome

Good times, bad times

    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Rheumatology
    • RX
    • Sports Medicine
    • Studies
View Post
  • 5 min
  • Findings from the TRACK-FA study

Neuroimaging biomarkers in Friedreich’s ataxia

    • Genetics
    • Neurology
    • Pediatrics
    • RX
    • Studies
View Post
  • 12 min
  • Doing sport without fear or risk

Doing sport without fear or risk

    • CME continuing education
    • Endocrinology and Diabetology
    • Pediatrics
    • RX
    • Sports Medicine
View Post
  • 8 min
  • Chronic inducible urticaria

What has stayed the same, what has changed?

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Doing sport without fear or risk
  • 2
    UV protection and skin cancer screening – Update 2025
  • 3
    Rare malignancy from a dermatological perspective
  • 4
    Yellow nail and Swyer-James syndrome
  • 5
    Diagnostic indications

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.